首页/数据集/A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273

A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273

NCATS Open Data2023-02-03 更新2026-08-08 收录

疫苗临床试验

新冠疫苗加强针

数据链接：

https://doi.org/10.1101/2023.01.24.23284869 数据链接链接失效反馈

官方服务：

资源简介：

A Randomized Trial Comparing Omicron-Containing Boosters with the Original Covid-19 Vaccine mRNA-1273

应用场景：

创建时间：

2023-01-24

疫苗临床试验

知情同意干预

Dataset with no observations Study Description A randomized, preliminary proof of concept study evaluating two types of supplemental information that would serve as an adjunct to the traditional infor

NIAID Data Ecosystem30

Dataset from Safety and Immunogenicity Study of GSK Biologicals' Candidate Tuberculosis Vaccine (692342) When Administered to Healthy Infants

疫苗临床试验

结核病预防

This purpose of the study is to assess the safety and immunogenicity of a GSK Biologicals' candidate tuberculosis vaccine (692342) when administered concomitantly with or after the Expanded Programme

NIAID Data Ecosystem20

Dataset from Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.

疫苗临床试验

免疫原性评估

This study is designed to assess the safety and immunogenicity of a GSK Biologicals' investigational vaccine GSK2321138A in adults 18 years old and older. This study is also designed to assess the lot

NIAID Data Ecosystem20

Characteristics of HVTN 502 and 503 trial participants.

疫苗临床试验

免疫基因型分析

Data shown are median values (interquartile range) unless otherwise indicated. * At time of sampling § HLA-B*27, B51, B*5701/03, B*5801 and B*8101 Characteristics of HVTN 502 and 503 trial participant

NIAID Data Ecosystem20

Demographic and clinical characteristics of Black participants in HVTN 503.

疫苗临床试验

黑人参与者特征

Demographic and clinical characteristics of Black participants in HVTN 503.

NIAID Data Ecosystem20